Ignite Creation Date:
2024-05-06 @ 4:12 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04901039
Status:
TERMINATED
Last Update Posted:
2024-03-07
First Post:
2021-05-20
Brief Title:
Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure
Sponsor:
Region Skane
Organization:
Region Skane
Study Overview
Official Title:
Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure
Status:
TERMINATED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of resources
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FLUID-AHF
Brief Summary:
Heart failure HF is the endstage of all heart disease characterized by inability of either the left or right heart or both to maintain sufficient output of blood for the demands of the body at normal filling pressures Patients with HF are often admitted to hospital with decompensation and treated with diuretics Residual congestion at discharge is associated with increased risk of early rehospitalization and adverse outcomes However determination of residual decompensation is complicated and a large number of patients admitted with decompensated heart failure are likely discharged before optimal decongestion has been achieved Lung ultrasound LUS is a promising method to determine residual decompensation with the evaluation of B-lines In this study our primary aim is to evaluate if LUS together with echocardiographic evaluation of filling pressure according to the European Society of Cardiology ESC algorithm performs better than clinical assessment to determine fluid status and risk of early rehospitalization in patients hospitalized for AHF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None